Try it
Pediatrics · Growth and development: treatment of central precocious puberty
Sample itemA 7-year-old girl has had breast development since age 6, a rapid growth rate and an advanced bone age. A GnRH stimulation test gives a pubertal LH peak, and the MRI of the brain is normal. What is the most appropriate treatment?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Depot GnRH agonist
A pubertal response to GnRH stimulation confirms central precocious puberty, and idiopathic disease is the commonest cause in girls. Long-acting GnRH agonists desensitise the pituitary, halt pubertal progression and slow bone-age advance, preserving adult height.
Option by option
A. Medroxyprogesterone acetate
This only partly suppresses menses and breast growth and does not stop bone-age advance.
B. Oral dexamethasone
Glucocorticoid suppression treats congenital adrenal hyperplasia, not central puberty.
C. Depot GnRH agonist (correct)
Correct. Continuous GnRH agonist exposure suppresses gonadotropin release in gonadotropin-dependent puberty.
D. Letrozole
Aromatase inhibitors are used in gonadotropin-independent forms such as McCune-Albright syndrome.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pediatrics questions
- Congenital heart diseaseWhich is the most common cyanotic congenital heart disease presenting beyond the neonata…
- NutritionWhich feature most clearly distinguishes kwashiorkor from marasmus?
- NeonatologyA newborn becomes visibly jaundiced in the first 24 hours of life. What is the most like…
- Diarrhoeal diseasesA child with diarrhoea has 'some dehydration'. What is the recommended initial management?